• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥地利 2016/17 至 2018/19 流感季期间循环流感病毒的异质性及其对流感病毒疫苗有效性的影响。

Heterogeneity of Circulating Influenza Viruses and Their Impact on Influenza Virus Vaccine Effectiveness During the Influenza Seasons 2016/17 to 2018/19 in Austria.

机构信息

Centre of Virology, Medical University Vienna, Vienna, Austria.

Department of Environmental Health, Medical University Vienna, Vienna, Austria.

出版信息

Front Immunol. 2020 Mar 17;11:434. doi: 10.3389/fimmu.2020.00434. eCollection 2020.

DOI:10.3389/fimmu.2020.00434
PMID:32256493
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7092378/
Abstract

The constantly changing pattern in the dominance of viral strains and their evolving subclades during the seasons substantially influences influenza vaccine effectiveness (IVE). In order to further substantiate the importance of detailed data of genetic virus characterization for IVE estimates during the seasons, we performed influenza virus type and subtype specific IVE estimates. IVE estimates were assessed using a test-negative case-control design, in the context of the intraseasonal changes of the heterogeneous mix of circulating influenza virus strains for three influenza seasons (2016/17 to 2018/19) in Austria. Adjusted overall IVE over the three seasons 2016/17, 2017/18, and 2018/19 were -26, 39, and 63%, respectively. In accordance with the changing pattern of the circulating strains a broad range of overall and subtype specific IVEs was obtained: A(H3N2) specific IVE ranged between -26% for season 2016/17 to 58% in season 2018/19, A(H1N1)pdm09 specific IVE was 25% for the season 2017/18 and 65% for the season 2018/19 and Influenza B specific IVE for season 2017/18 was 45%. The results obtained in our study over the three seasons demonstrate the increasingly complex dynamic of the ever changing genetic pattern of the circulating influenza viruses and their influence on IVE estimates. This emphasizes the importance of detailed genetic virus surveillance for reliable IVE estimates.

摘要

在季节期间,病毒株及其不断演变的亚系优势的不断变化模式极大地影响了流感疫苗的有效性(IVE)。为了进一步证实详细的遗传病毒特征数据对于季节期间 IVE 估计的重要性,我们进行了流感病毒类型和亚型特异性 IVE 估计。在奥地利的三个流感季节(2016/17 至 2018/19)中,我们在季节内循环流感病毒株的异质混合变化的背景下,使用病例对照测试阴性设计评估了 IVE 估计。调整后的三个季节 2016/17、2017/18 和 2018/19 的总体 IVE 分别为-26%、39%和 63%。与循环株的变化模式一致,获得了广泛的总体和亚型特异性 IVE:A(H3N2)特异性 IVE 范围为 2016/17 季节的-26%至 2018/19 季节的 58%,A(H1N1)pdm09 特异性 IVE 为 25% 2017/18 赛季和 65% 2018/19 赛季,2017/18 赛季流感 B 特异性 IVE 为 45%。我们在三个季节中获得的研究结果表明,循环流感病毒不断变化的遗传模式及其对 IVE 估计的影响越来越复杂。这强调了详细的遗传病毒监测对于可靠的 IVE 估计的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf9/7092378/4d35e4c87e4f/fimmu-11-00434-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf9/7092378/87b13fa37b72/fimmu-11-00434-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf9/7092378/4d35e4c87e4f/fimmu-11-00434-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf9/7092378/87b13fa37b72/fimmu-11-00434-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf9/7092378/4d35e4c87e4f/fimmu-11-00434-g0002.jpg

相似文献

1
Heterogeneity of Circulating Influenza Viruses and Their Impact on Influenza Virus Vaccine Effectiveness During the Influenza Seasons 2016/17 to 2018/19 in Austria.奥地利 2016/17 至 2018/19 流感季期间循环流感病毒的异质性及其对流感病毒疫苗有效性的影响。
Front Immunol. 2020 Mar 17;11:434. doi: 10.3389/fimmu.2020.00434. eCollection 2020.
2
Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.2003/2004年至2013/2014年荷兰流感疫苗的有效性:流行的流感病毒类型和亚型的重要性
PLoS One. 2017 Jan 9;12(1):e0169528. doi: 10.1371/journal.pone.0169528. eCollection 2017.
3
Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.2015/2016 流感季节,60 岁及以上人群中,流感疫苗对 A(H1N1)pdm09 或 B/维多利亚系的预防效果较低,且既往接种对预防该病毒感染入院的效果也不佳。
Vaccine. 2017 Dec 19;35(52):7331-7338. doi: 10.1016/j.vaccine.2017.10.100. Epub 2017 Nov 8.
4
Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season.2017/18 流感季西班牙巴伦西亚地区 60 岁及以上住院成年人中流感疫苗对实验室确诊流感的效果。
Euro Surveill. 2019 Aug;24(31). doi: 10.2807/1560-7917.ES.2019.24.31.1800461.
5
Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.在一个同时流行三种流感病毒型/亚型的季节里,对欧洲流感疫苗有效性的评估:I-MOVE 多中心病例对照研究,2012/13 年流感季节。
Euro Surveill. 2014 Feb 13;19(6):20701. doi: 10.2807/1560-7917.es2014.19.6.20701.
6
2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.2012/13 年度流感疫苗对住院的甲型 H1N1pdm09、甲型 H3N2 和乙型流感的效果:来自一个欧洲医院网络的估计。
Euro Surveill. 2015 Jan 15;20(2):21011. doi: 10.2807/1560-7917.es2015.20.2.21011.
7
Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.2018/19 年度意大利季节性流感中,中等强度的流感疫苗对 A(H1N1)pdm09 病毒有效,对 A(H3N2)亚型的效果较低。
Expert Rev Vaccines. 2019 Nov;18(11):1201-1209. doi: 10.1080/14760584.2019.1688151. Epub 2019 Nov 12.
8
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.2014/15 年在欧洲,I-MOVE 多中心病例对照研究中,在甲型 H1N1pdm09、乙型和漂移型甲型 H3N2 流感共同流行的季节,初级保健患者中预防实验室确诊流感的疫苗效力。
Euro Surveill. 2016;21(7):pii=30139. doi: 10.2807/1560-7917.ES.2016.21.7.30139.
9
Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.2014 - 15年度西班牙流感疫苗对轻度实验室确诊的甲型(H3N2)流感和乙型流感的保护作用减弱。
Vaccine. 2016 Apr 29;34(20):2371-7. doi: 10.1016/j.vaccine.2016.03.035. Epub 2016 Mar 25.
10
Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.希腊六季(2013-2014 至 2018-2019 年)流感疫苗对住院确诊流感的有效性:一项汇总分析。
Vaccine. 2020 Mar 10;38(12):2715-2724. doi: 10.1016/j.vaccine.2020.01.083. Epub 2020 Feb 6.

引用本文的文献

1
Seasonal Influenza Vaccine Effectiveness in Persons Aged 15-64 Years: A Systematic Review and Meta-Analysis.15至64岁人群中季节性流感疫苗的有效性:一项系统评价与荟萃分析
Vaccines (Basel). 2023 Aug 4;11(8):1322. doi: 10.3390/vaccines11081322.
2
The evolutionary footprint of influenza A subtype H3N2 strains in Bangladesh: implication of vaccine strain selection.孟加拉国甲型 H3N2 亚型流感病毒株的进化足迹:对疫苗株选择的启示。
Sci Rep. 2022 Sep 28;12(1):16186. doi: 10.1038/s41598-022-20179-7.
3
Influenza Vaccine Effectiveness and Waning Effect in Hospitalized Older Adults. Valencia Region, Spain, 2018/2019 Season.

本文引用的文献

1
End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18.2017/18 年度英国成人和儿童季节性流感疫苗的有效性。
Euro Surveill. 2019 Aug;24(31). doi: 10.2807/1560-7917.ES.2019.24.31.1800488.
2
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019.2018/19 年度流感疫苗中期效力:2018 年 10 月至 2019 年 1 月的六项欧洲研究。
Euro Surveill. 2019 Feb;24(8). doi: 10.2807/1560-7917.ES.2019.24.1900121.
3
Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19.
西班牙 Valencia 地区 2018/2019 年度住院老年人群中流感疫苗的有效性和效果减弱情况。
Int J Environ Res Public Health. 2021 Jan 27;18(3):1129. doi: 10.3390/ijerph18031129.
2018/19 年冬季流感季,香港儿童因流感住院的流感疫苗预防效果的早期季节估计。
Euro Surveill. 2019 Jan;24(5). doi: 10.2807/1560-7917.ES.2019.24.5.1900056.
4
Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019.2018/19 年度流感 A(H1N1)pdm09 疫苗效力的临时估计数,加拿大,2019 年 1 月。
Euro Surveill. 2019 Jan;24(4). doi: 10.2807/1560-7917.ES.2019.24.4.1900055.
5
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010-2011 to 2017-2018.疫苗对加拿大 8 个季节(2010-2011 年至 2017-2018 年)中匹配和不匹配的流感 B 病毒的有效性。
Clin Infect Dis. 2019 May 2;68(10):1754-1757. doi: 10.1093/cid/ciy876.
6
Early Bird Gets the Flu: What Should Be Done About Waning Intraseasonal Immunity Against Seasonal Influenza?早起的鸟儿会得流感:季节性流感季节内免疫减弱该如何应对?
Clin Infect Dis. 2019 Mar 19;68(7):1235-1240. doi: 10.1093/cid/ciy748.
7
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies.2017/18 年流感季节疫苗的中期效力:来自五个欧洲研究的综合结果。
Euro Surveill. 2018 Mar;23(9). doi: 10.2807/1560-7917.ES.2018.23.9.18-00086.
8
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.2017/18 年流感疫苗效力的临时估计:2018 年 1 月加拿大甲型 H3N2 和乙型(山形)流感早期同时流行。
Euro Surveill. 2018 Feb;23(5). doi: 10.2807/1560-7917.ES.2018.23.5.18-00035.
9
End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17.2016/17年英国成人和儿童季末流感疫苗的有效性
Euro Surveill. 2017 Nov;22(44). doi: 10.2807/1560-7917.ES.2017.22.44.17-00306.
10
Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.超越抗原匹配:迈向对流感疫苗效力的更深入理解
J Infect Dis. 2017 Dec 19;216(12):1477-1480. doi: 10.1093/infdis/jix527.